The prevalence of high risk of obstructive sleep apnea in patients with allergic rhinitis
Issued Date
2022-09-01
Resource Type
ISSN
0125877X
eISSN
22288694
Scopus ID
2-s2.0-85093852766
Pubmed ID
31677615
Journal Title
Asian Pacific Journal of Allergy and Immunology
Volume
40
Issue
3
Start Page
205
End Page
209
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Allergy and Immunology Vol.40 No.3 (2022) , 205-209
Suggested Citation
Wongvilairat S., Assanasen P., Banhiran W., Tantilipikorn P., Bunnag C. The prevalence of high risk of obstructive sleep apnea in patients with allergic rhinitis. Asian Pacific Journal of Allergy and Immunology Vol.40 No.3 (2022) , 205-209. 209. doi:10.12932/ap-141218-0458 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/84928
Title
The prevalence of high risk of obstructive sleep apnea in patients with allergic rhinitis
Author's Affiliation
Other Contributor(s)
Abstract
Background: Although allergic rhinitis (AR) has not been acknowledged as a strong risk factor for obstructive sleep apnea (OSA), several pathophysiological linkages between these two conditions have frequently been reported. However, epidemiological data relating to the prevalence of OSA in patients with AR remain scarce. Objective: To investigate the prevalence of patients at high risk for OSA among patients with AR, and to determine the relationship between OSA and severity of AR. Methods: Patients aged ≥ 18 years with a diagnosis of AR and positive skin prick test were recruited from the allergy clinic, Department of Otorhinolaryngology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand between October 2014 to November 2015. During routine follow-up, participants were asked to complete the STOP-Bang questionnaire and visual analog scale regarding AR symptoms, including their duration and severity. Patients with STOP-Bang score of ≥ 3 were considered as high risk for having OSA. Results: Of the 120 AR patients (45 males, 75 females) included, there were 28 patients (19 males, 9 females) who had a STOP-Bang score of ≥ 3 (23.3%), especially for those who had longer duration of AR symptoms (low-risk/high-risk: 60/120 months, p = 0.01). However, no significant relationship was observed between ARIA classification and severity of nasal symptoms of AR for being high risk of OSA. Conclusion: The prevalence of high risk of having OSA in patients with AR was two times higher than that in general Thai population. Early screening and further management for these patients may improve treatment outcomes and quality of life.